Hornstein Max, Hoffmann Michèle J, Alexa Adrian, Yamanaka Masanori, Müller Mirko, Jung Volker, Rahnenführer Jörg, Schulz Wolfgang A
Department of Urology, Heinrich Heine University, Dusseldorf, Germany.
Cancer Genomics Proteomics. 2008 Mar-Apr;5(2):123-36.
Allelic losses on chromosome 8p are common in prostate carcinoma, but it is not known exactly how they contribute to cancer development and progression.
Expression of 12 genes located across chromosome 8p, including established tumor suppressor candidates (CSMD1, DLC1, NKX3.1), and others from a new microarray-based comparison was studied by quantitative RT-PCR in 45 M0 prostate carcinomas and 13 benign prostate tissues.
Significantly reduced expression was observed for two protein phosphatase subunit genes (PPP2CB, PPP3CC) and two TRAIL decoy receptors (TNFRSF10C/DcR1, TNFRSF10D/DcR2), but not for the three established candidates nor for TRAIL death receptor genes. Low expression of PPP3CC and TNFRSF10C located at 8p21.3 was highly significantly associated with tumor recurrence. In addition to allele loss, down-regulation of TNFRSF10C and TNFRSF10D was found to be associated with hypermethylation, although bisulfite sequencing usually revealed it to be partial.
Our data strongly support a recent proposal that a segment at 8p21.3 contains crucial prostate cancer tumor suppressors. In addition, they raise the paradoxical issue of why TRAIL decoy receptors rather than death receptors are down-regulated in aggressive prostate cancer.
8号染色体短臂上的等位基因缺失在前列腺癌中很常见,但尚不清楚它们如何具体促进癌症的发生和发展。
通过定量逆转录聚合酶链反应(quantitative RT-PCR),研究了位于8号染色体短臂上的12个基因的表达情况,这些基因包括已确定的肿瘤抑制候选基因(CSMD1、DLC1、NKX3.1)以及其他来自基于微阵列的新比较研究中的基因,样本包括45例M0期前列腺癌和13例良性前列腺组织。
观察到两个蛋白磷酸酶亚基基因(PPP2CB、PPP3CC)和两个TRAIL诱饵受体(TNFRSF10C/DcR1、TNFRSF10D/DcR2)的表达显著降低,但三个已确定的候选基因以及TRAIL死亡受体基因的表达未降低。位于8p21.3的PPP3CC和TNFRSF10C低表达与肿瘤复发高度显著相关。除了等位基因缺失外,还发现TNFRSF10C和TNFRSF10D的下调与高甲基化有关,尽管亚硫酸氢盐测序通常显示其为部分甲基化。
我们的数据有力地支持了最近的一项提议,即8p21.3区域包含关键的前列腺癌肿瘤抑制基因。此外,这些数据还提出了一个自相矛盾的问题:为什么在侵袭性前列腺癌中TRAIL诱饵受体而非死亡受体被下调。